4//SEC Filing
Hamermesh Joshua 4
Accession 0001209191-07-038095
CIK 0001340752other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:49 PM ET
Size
11.6 KB
Accession
0001209191-07-038095
Insider Transaction Report
Form 4
Hamermesh Joshua
VP Comm & Bus Development
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2007-06-19−8,333→ 25,000 totalExercise: $3.00Exp: 2015-07-01→ Common Stock (8,333 underlying) - Exercise/Conversion
Common Stock
2007-06-19$3.00/sh+8,333$24,999→ 8,333 total
Footnotes (1)
- [F1]75% of the underlying shares vest in equal annual installments over a four year period beginning on April 14, 2006. The balance of the underlying shares vests on April 14, 2009, subject to acceleration upon reaching certain milestone performance objectives.
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeother
Related Parties
1- filerCIK 0001388396
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 5:49 PM ET
- Size
- 11.6 KB